Literature DB >> 11516852

Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function.

C W Stevens1, R F Munden, K M Forster, J F Kelly, Z Liao, G Starkschall, S Tucker, R Komaki.   

Abstract

PURPOSE: To determine whether superior-inferior lung tumor motion is predictable by tumor size or location, or pulmonary function test results. METHODS AND MATERIALS: Superior-inferior tumor motion was measured on orthogonal radiographs taken during simulation of 22 patients with inoperable lung cancer diagnosed by orthogonal radiographs.
RESULTS: The tumor size averaged 5.5 +/- 3.1 cm (range 1.5-12 cm). Seven of 11 central tumors demonstrated some motion compared with 5 of 11 peripheral tumors. Four of 5 upper lobe tumors moved compared with 8 of 17 tumors that were either middle or lower lobe lesions. The mean fourth rib motion was 7.3 +/- 3.2 mm (range 2-15). The mean FeV(1) was 1.8 +/- 1.2 (range 0.55-5.33. The mean diffusing capacity of the lung for carbon monoxide was 14.0 +/- 6.5 (range 7.8-21.9). The mean total lung capacity was 6.5 +/- 1.2 (range 3.3-8.4). None of these parameters correlated with tumor motion. Although lateral tumor motion could not be consistently determined, 1 tumor moved 10 mm anterior-posteriorly.
CONCLUSIONS: Lung tumors often move significantly during respiration. Tumor motion is not predictable by tumor size or location, or pulmonary function test results. Therefore, tumor motion must be measured in all patients. Measurement in three dimensions will likely be necessary to maximize the irradiated lung volumes or choose beam arrangements parallel to the major axis of motion.

Entities:  

Mesh:

Year:  2001        PMID: 11516852     DOI: 10.1016/s0360-3016(01)01621-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  51 in total

1.  A novel technique for markerless, self-sorted 4D-CBCT: feasibility study.

Authors:  Irina Vergalasova; Jing Cai; Fang-Fang Yin
Journal:  Med Phys       Date:  2012-03       Impact factor: 4.071

2.  Thoracic target volume delineation using various maximum-intensity projection computed tomography image sets for radiotherapy treatment planning.

Authors:  David A Zamora; Adam C Riegel; Xiaojun Sun; Peter Balter; George Starkschall; Osama Mawlawi; Tinsu Pan
Journal:  Med Phys       Date:  2010-11       Impact factor: 4.071

3.  Dose-mass inverse optimization for minimally moving thoracic lesions.

Authors:  I B Mihaylov; E G Moros
Journal:  Phys Med Biol       Date:  2015-04-24       Impact factor: 3.609

Review 4.  A review of intensity-modulated radiation therapy.

Authors:  Laurie E Gaspar; Meisong Ding
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

5.  Changes in chest wall thickness during four-dimensional CT in particle lung treatment planning.

Authors:  S Mori; N Yamamoto; M Nakajima; M Baba
Journal:  Br J Radiol       Date:  2011-08       Impact factor: 3.039

Review 6.  Current status and future prospects of multi-dimensional image-guided particle therapy.

Authors:  Shinichiro Mori; Silvan Zenklusen; Antje-Christin Knopf
Journal:  Radiol Phys Technol       Date:  2013-02-19

7.  Target definition of moving lung tumors in positron emission tomography: correlation of optimal activity concentration thresholds with object size, motion extent, and source-to-background ratio.

Authors:  Adam C Riegel; M Kara Bucci; Osama R Mawlawi; Valen Johnson; Moiz Ahmad; Xiaojun Sun; Dershan Luo; Adam G Chandler; Tinsu Pan
Journal:  Med Phys       Date:  2010-04       Impact factor: 4.071

8.  Modern radiotherapy using image guidance for unresectable non-small cell lung cancer can improve outcomes in patients treated with chemoradiation therapy.

Authors:  Matthew P Deek; Sinae Kim; Ning Yue; Rekha Baby; Inaya Ahmed; Wei Zou; John Langenfeld; Joseph Aisner; Salma K Jabbour
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

9.  Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer.

Authors:  Ursula Nestle; Andrea Schaefer-Schuler; Stephanie Kremp; Andreas Groeschel; Dirk Hellwig; Christian Rübe; Carl-Martin Kirsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-10-21       Impact factor: 9.236

10.  Dynamic MR based analysis of tumor movement in upper and mid lobe localized lung cancer.

Authors:  A Kovacs; J Hadjiev; F Lakosi; G Antal; C Vandulek; E Somogyine Ezer; P Bogner; A Horvath; I Repa
Journal:  Pathol Oncol Res       Date:  2008-09-24       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.